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INTRODUCTION 
Previous studies  of pneumococcal transformation  have been concerned in 
the main with the conversion of R  organisms derived from one specific type to 
S  organisms of heterologons type.  The present investigations are concerned 
with intratype conversion or transformation of pneumococci.  A stable variant 
of pneumococcns Type II, intermediate between the classical R  and S forms, 
has been  isolated.  It  has  been  demonstrated  that  the  variant  produces a 
certain amount of specific capsular polysaccharide (SSSII) although it does not 
possess a demonstrable capsule nor does it form colonies with a smooth surface 
similar to those of S organisms.  The gene-like material controlling the forma- 
tion of SSSII has been separated from the intermediate variant and transferred 
in ~itro to an R  strain of pneumococcus which thereby assumes certain charac- 
teristics of the intermediate.  The transformed R  strain retains its rough colo- 
nial form, produces SSSII, but has no demonstrable capsule.  In addition, the 
intermediate  has  been  converted in  ~o  to  a  fully  encapsulated  strain  of 
pneumococcus Type II. 
A variety of variants intermediate between the R and S forms of pneumococci have 
been described before.  Blake and Trask (1) in 1923 noted the presence of intermedi- 
ates derived from pneumococcus Type I  and described  5 of these in detail 10 years 
later (2).  Of the 5 intermediate variants derived from Type I by serial cultivation in 
broth containing Type I antipneumococcal  serum, 2 were relatively stable on cultiva- 
tion in broth, but both of these reverted to fully encapsulated Type I  S on mouse 
passage.  Blake and Trask (2) likewise described  an intermediate originating from 
pneumococcus  Type II.  The  occurrence of  intermediate variants  has  also  been 
reported by Dawson (3), Neufeld and Levinthal (4), Klumpen (5), Paul (6), and by 
others. 
It has been customary in the past to consider that cultivation of S pneumo- 
cocci in  media  containing homologous anticapsular  antibodies  suppresses  in 
some  manner  the  polysaccharide-synthesizing  mechanism,  and  that  con- 
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versely, the reversion of R  pneumococci to the homologous S form on cultivation 
in  anti-R  serum  involves reactivation  of  capsular  synthesis.  In  the  light  of 
modern knowledge  it seems  more probable  that  R  and  intermediate  mutants 
occur  in  cultures  of  pneumococci  of  various  specific  types  and  that  these 
mutants  have  a  selective advantage  when  the  predominantly  S  cultures  are 
grown in the presence of anti-S serum.  Similarly, some, but not all, cultures of 
R  pneumococci  contain  a  small  number  of  S  and  intermediate  forms  or  else 
occasionally throw off S  mutants  which are selected when cultivated in anti-R 
serum or injected into mice.  That the degradation from S  to R  may involve a 
stepwise loss of characters  is indicated  by  earlier reports  (1-6).  The present 
studies  describe  a  specifically directed,  stepwise  restoration  from  R  to  inter- 
mediate and then to the fully encapsulated S form. 
Materials  and Metkods 
1. Preparalion of Transforming Extracts.--In  previous  methods  for  the  preparation  of 
transforming extracts (7) the bacterial cells obtained by centrifuging young broth cultures of 
encapsulated  pneumococci have  served as  the starting  material.  Very large amounts  of 
broth culture must be used to obtain even a modest amount of active transforming extract. 
In the present method advantage was taken of the mass culture technique in which an excess 
of glucose is added to the medium and the acid produced during  the course of growth is neu- 
tralized intermittently with NaOH.  A much greater yield of bacterial cells per volume of 
medium can be obtained under these circumstances.  In addition, by observation of the rate 
of glucose utilization, the transforming material can be harvested from bacteria in the more 
active phase of growth. 
One liter of nutrient broth prepared from fresh beef heart infusion and containing 1 per 
cent neopeptone was seeded with 15 cc. of the supernatant of an 18 hour rabbit blood broth 
culture of pneumococci.  Mter incubation at 37°C. for approximately 16 hours, the organisms 
were all, or virtually all, Gram-positive.  Glucose was then added to a final concentration of 
0.5 per cent and 1 cc. of 0.5 per cent phenol red in 95 per cent alcohol was added as indicator of 
acid production (0.0005 per cent phenol red):  Following the addition of glucose, incubation 
was continued for a period of 3 to 6 hours depending on the growth characteristics of the strain 
of pneumococcus.  During the last 15 minutes the culture was grown in the presence of 0.001 
molar sodium citrate to inhibit destruction of the transforming principle (8).  Growth was 
stopped when the slope of the curve for the addition of alkali began to fall off.  At this time 
sodium citrate was added to a concentration of 0.1 ~.  Sodium desoxycholate was then added 
to a concentration of 0.05  per cent.  The broth culture, which had been creamy with cells, 
cleared within approximately 3 minutes and became only moderately opalescent and somewhat 
viscous depending on the type of pneumoeoccus that was lysed. 
An attempt  to grow pneumococci in the presence of a  small amount of sodium citrate 
(0.0001 x0 was made but abandoned because the growth rate was reduced to about one-third 
that obtained in citrate-free medium. 
To the desoxycholnte-lysed culture, one volume of alcohol was added with shaking where- 
upon a white fibrous precipitate separated out.  The mixture was centrifuged and the super- 
natant discarded.  The precipitate was dissolved in 100 cc. of 0.1 K sodium chloride solution 
containing 0.1 ~  sodium citrate.  Protein was removed by repeated shaking with a mixture 
of 20 cc. of chloroform and 5 cc. of octyl alcohol in a  shaking machine.  After the third 
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face following centrifugation.  The transforming principle was then precipitated with two 
volumes of alcohol.  The active principle was partially purified by dissolving the precipitate 
in saline and reprecipitating with two volumes of alcohol.  After the second precipitation the 
active fraction appeared as a dense white fibrous mass. 
A difficulty encountered through addition of 0.1 ~  sodium citrate is the precipitation of 
large amounts of crystalline sodium citrate when one volume of alcohol is added and the 
mixture allowed to stand overnight in the cold.  The active fraction becomes entrapped in the 
crystalline deposit.  This difficulty can be avoided by completing the separation and partial 
purification of the desoxyribonucleic acid fraction during the course of a  single day,  and 
avoiding storage in the ice box during these stages. 
2.  Transformation Reactions in Vitro.--A method previously described (7) was used with 
minor modifications.  One drop of a 10  -4 dilution of an 18 hour blood broth culture of the R 
or intermediate variant of Type II pneumococcus was seeded into charcoal-absorbed broth 
containing an appropriate amount of transforming principle and I0 per cent anti-R pleural 
fluid which had been heated previously at 60  ° for 30 minutes.  The volume of broth, chest 
fluid, and transforming principle was 2 cc. in all.  Mter 24 hours' incubation, transfers were 
streaked on the surface of blood agar plates and subcultures of the supernatant were made in 
I0 per cent anfi-R serum broth with or without further addition of transforming principle. 
The supernatants of all cultures were examined carefully for turbidity as an indication of the 
occurrence of transformation.  In all instances the experiments were set up in duplicate. 
3.  Transformalgon  Reactions i, Vi~o.--The technique followed was that described originally 
by Gri~th (9) in which mice are injected subcutaneously with small amounts of living R 
forms mixed with large amounts of heat-killed smooth organisms. 
To obtain a  mass growth of smooth organisms, a  liter of neopeptone infusion broth was 
seeded with smooth pneumococci and incubated at 37°C. overnight.  The next morning 10 
gin. of glucose was added and the culture was incubated for 6~ hours with intermittent neu- 
tralization.  During the last half-hour the culture grew in the presence of 0.001 ~  sodium 
citrate.  The culture was then centrifuged in the presence of approximately 0.1 ~t sodium 
citrate and the pneumococci were resuspended in 0.1 ~  sodium citrate--normal saline solution. 
The organisms were killed by heating at 65°C. for 30 minutes in a water bath.  Pyrex tubes 
were half filled with the bacterial suspension.  The mouth of each tube was flamed thoroughly 
and the tubes immersed in the water bath to the lip.  The suspension of heat-killed organisms 
was streaked on blood agar plates, inoculated into broth and injected into mice.  There was 
no evidence of living pneumococci from any of these tests. 
White mice of the CFW strain were injected subcutaneously in the lower abdominal region 
with 0.1 cc. of an 18 hour blood broth culture of R  pneumocoeci and the suspension of heat- 
killed S organisms in an amount sufficient to  make the mixture as turbid as possible and still 
allow injection through a No. 25 hypodermic needle.  A total volume of 0.5 cc.  was injected 
into each mouse.  Upon death of the mice, organisms obtained from peritoneal washings 
and cultures of heart blood were examined for capsular swelling with type-specific serum and 
the heart blood was streaked on rabbit blood agar plates for subsequent study. 
4. Strains of Pneumococcus.--D39/S: a fully encapsulated strain of pneumococcus Type II. 
D39/RI9:  a  rough strain obtained by growing the Type II S strain D39/S for 19 serial 
transfers in Type II antipneumocoecal rabbit serum. 
D39/Int53: a  strain intermediate between the classical R  and S  forms with respect to 
SSSII formation, derived from the rough strain D39/R19 by selection. 
R36NC:  colonial variant of the rough strain R36 which was used in studies by Avery, 
MacLeod, and McCarty (7).  R36 was derived originally from Type II strain D39S. 
A/66: a fully encapsulated strain of pneumococcus Type III also used in previous studies 
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5.  Anti-R  Semm.--Sterile pleural fluids containing R  agglutinins were  obtained from 
patients suffering from streptococcal pneumonia and tuberculosis respectively.  The pleural 
fluids were clarified by centrifugation and heated at 60  ° for 30 minutes before being used in 
the tests. 
EXPEI~NTAL 
Isolation of Intermediate Variant D39/Int53.--Dawson  (10)  observed that 
in broth cultures seeded with different amounts of R  and S pneumococci the 
same relative proportions of R  and S forms were maintained for several trans- 
fers.  In other words, when R and S pneumococci are grown together in broth 
culture, neither form appears to have a  selective advantage over the other. 
This observation of Dawson's has been confirmed in the present study.  How- 
ever, when an anti-R serum is added to the medium, S pneumococci appear to 
have a  selective advantage over R  although it is possible that some R  cells 
under  these  circumstances  might  be  transformed  to  S  ceils  because  of  the 
transforming principle present in the S organisms. 
When a mixed culture containing a large seeding of R  organisms and a com- 
paratively small number of S  organisms is grown in broth it is a  matter of 
chance whether any S  forms will be carried along when transfers are made 
using  only a  loopful of whole culture.  On the other hand,  if such a  mixed 
culture is grown in the presence of anti-R serum, the R  organisms are agglu- 
tinated in the bottom of the tube and unagglutinated organisms grow through- 
out the supernatant.  Thus when a mixed culture is grown in the presence of 
anti-R serum and the supernatant only transferred, the unagglutinated organ- 
isms will be recovered even though they are present in comparatively small 
number in the original inoculum. 
When the cells from 10 cc. of whole broth culture of the rough strain D39/R19 
and 1 X  10  -s cc. of culture of the smooth strain D39/S were inoculated together 
into 4 cc. of 10 per cent anti-R serum broth, S pneumococci were demonstrated 
on plating the first subculture even though the ratio of R  to S in the original 
inoculum was 109:1.  The transfer was made by centrifuging the 24 hour mixed 
culture for 5 minutes at low speed to pack the R cells and transferring the entire 
supernatant to 4 cc. of l0 per cent anti-R serum  broth.  The original mixed 
culture was grown in a long narrow tube, 12.5 cm. by 8 ram.  This afforded a 
tall  column of medium through which non-agglutlnated organisms could grow 
and permitted easy removal of the superuatant.  Tubes of this sort axe not a 
necessary prerequisite but make it  easier to obtain the supernatant  relatively 
free of R  cells.  The efficiency of this method of selection is indicated by the 
ease with  which  1-3  S  cells could be  detected when  inoculated along with 
109 R  cells. 
By using this technique it was found that when the rough strain D39/R19 
was grown in 10 per cent anti-R serum broth and all or only a Ioopful of super- 
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could  be  selected  readily  in  three  subcultures.  These  variants,  although 
forming colonies with a rough surface, were not agglutinated when grown in 10 
per cent anti-R serum broth. 
A similar, if not identical intermediate variant was isolated by chance from 
subcultures of a single colony of the rough strain D39/R19 by repeated transfer 
of a loopful of whole culture to fresh 10 per cent anti-R serum broth.  At the 
14th transfer a faintly turbid supernatant was present and in 53 subsequent 
transfers almost all of the organisms failed to be agglutinated by the anti-R 
serum  and  grew  diffusely  in  the  superuatant.  This  intermediate variant, 
designated D39/Int53, forms rough colonies on blood agar, is not agglutinated 
in anti-R serum broth,  but  is readily agglutinated to high  titer by a  true 
anti-SiI serum.  It appears to be an intermediate between the classical R and 
S forms of pneumococci.  Classical encapsulated S forms, which grow in smooth 
colonies on blood agar, were not encountered  at any time either when super- 
natants only or whole mixed cultures of D39/R19 were repeatedly transferred 
in anti-R serum broth.  There is no evidence, therefore,  that cultures of the 
rough strain D39/R19 contain any encapsulated Type II pneumococci. 
Production of SSSII  by  the Intermediate  Variant  D39/Int53.--Faflure  of 
strain D39/Int53 to be agglutinated when cultivated in anti-R serum broth, 
even though it still forms a rough surfaced colony on blood agar, suggested that 
a component is present on the surface of organsism of this intermediate variant 
which is absent from classical R organisms.  It seemed likely that the surface 
component is the Type II polysaccharide,  though present in an amount in- 
sufficient to give the colonies of D39/Int53 the characteristic  smooth, glistening 
appearance of encapsulated  pneumococci.  Immunological  evidence indicates 
clearly that the intermediate variant produces SSSII identical with that formed 
by encapsulated pneumococci of the smooth strain D39/S  but in  markedly 
reduced amount. 
Antisera prepared in rabbits by immunization with the intermediate variant 
D39/Int53 gave precipitin reactions  with purified Type II capsular  polysac- 
charide diluted to 1:5,000,000 and protected mice against infection with fully 
virulent  Type  II  pneumococci.  Moreover,  such  sera  agglutinated  fully 
encapsulated Type II pneumococci to a  titer equal to the best obtained by 
immunization with the smooth strain itself as shown in Table I.  The same 
sera agglutinated the intermediate variant to a much higher titer.  Further- 
more,  a  sample  of serum  prepared by immunization with the smooth strain 
D39/S, and repeatedly absorbed  with R  organisms until it no longer caused 
their agglutination, maintained its original titer against the smooth strain and 
also against the intermediate variant.  This is also shown in Table I.  On the 
other hand,  when  antiserum to  the  smooth  strain  was  absorbed  with  the 
intermediate variant, its agglutinating capacity for both strains was removed, 
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with smooth Type II encapsulated organisms removed the agglutinins for both 
intermediate and smooth strains.  This shows that the specific soluble  sub- 
stance produced by both strains is identical. 
The difference in the agglutinating titers of the various sera for the smooth 
and intermediate strains is of some significance with respect  to the amount of 
SSSII present on the surface of the cells.  Titers with the intermediate strain 
are invariably much higher than with S organisms.  The amount of polysac- 
charide available for combination with antibody is greater in the case of the 
fully encapsulated  smooth  strain  than  with  the  intermediate variant  and, 
accordingly,  the agglutination titer with the smooth strain would be expected 
to be lower since each cell would be able to combine with more antibody than 
each cell of the intermediate variant. 
TABLE  I 
Agglutination  Reactions  with Antisera to Smooth  Type II Pneumococcus  Strain D39/S,  and 
to the Intermediate  Variant D39/Int53 
Antiserum 
Anti-D39/S (smooth strain) 
"  absorbed with R  pneumococci 
"  "  "  intermediate variant D39/ 
Int53 
Anti-D39/Int53 (intermediate variant) 
"  absorbed with smooth strain D39/S 
Agglutination titers 







Suspension of inter- 







Absorption of antiserum to the intermediate variant with the fully encapsu- 
lated strain D39/S  was  accomplished  relatively easily.  However,  with the 
intermediate variant, D39/Int53, repeated absorptions  of Type II antiserum 
with very large  amounts of organisms  were necessary  to remove  completely 
anti-SSSII.  Probably this is because of the much smaller  amount of SSSII 
produced by the intermediate variant as compared with the encapsulated strain 
since the amount of antibody in the two samples of serum was comparable  as 
shown by the agglutination titers recorded in Table I. 
Further evidence for the greatly decreased production of SSSII by the inter- 
mediate strain is shown by precipitin  tests using an antiserum prepared against 
the smooth strain D39/S from which all anti-R antibodies had been removed by 
absorption,  and culture supernatants of the respective smooth and intermediate 
variants.  The cultures were grown in plain broth for 16 hours at 37°C.  There 
was no obvious difference in the amount of growth of the two strains as indi- 
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dilutions of culture supernatants were added to R-absorbed Type II antiserum 
diluted in saline in the proportion of 2:3.  The results of these precipitin reac- 
tions are recorded in Table II. 
From the results shown in Table II it can be seen that although the culture 
supernatant of D39/S when diluted 1:10 gives a well marked precipitin reaction 
with R-absorbed Type II antiserum, and a  trace of precipitation at 1:20, the 
supernatant of the intermediate variant shows only a  trace of reaction when 
diluted 1: 2. 
Preparations of purified SSSII in a  dilution of 1:2,500,000 gave a  definite 
precipitin reaction with the R-absorbed Type II antiserum used in the tests 
recorded in Table II. 
The question of the quantitative production of SSSII by the intermediate 
variant was not further explored except for a  single attempt to isolate SSSII 
from the autolysate of a mass culture of D39/Int53 grown in the presence of 1 
TABLE II 
Precipitin Reactions of Culture Supernatants of Smooth and Intermediate Organisms with 
Anti-lI S Serum Absorbed with R Organisms 
Strain 
D39/S (smooth strain) 
D39/Int53 (intermediate variant) 




1:10  [  1:20  1:200 
++  and ++++  indicate the relative intensities of the precipitin reactions. 
per  cent  glucose  employing  intermittent  neutralization.  The  amount  of 
SSSII, as indicated by precipitin reactions, was so small as to make isolation 
from other cell constituents impracticable. 
Failure to  Demonstrate  a  Capsular  Swelling Reaction with  the  Intermediate 
Variant.--The  observations  described  above  indicate  that  the  intermediate 
variant produces SSSII although  in  an  amount  considerably less  than  that 
produced by encapsulated organisms.  In addition, SSSII would appear to be 
disposed over the surface of the cells since they are no longer agglutinated by an 
anti-R serum but are agglutinated by Type II antiserum.  It was of interest, 
therefore, to determine whether capsular swelling could be demonstrated with 
the intermediate variant. 
D39/Int53 was grown under various conditions: in blood broth for 18 hours 
at 37°C., in broth containing 5 per cent normal horse serum for 4 to 6 hours, 
and in broth containing 5 per cent glucose for the same period.  Pneumococci 
cultivated under these conditions and obtained from the peritoneal washings 
of mice that died following injection of 1 co. of an 18 hour blood broth culture of 
the intermediate variant were tested for the capsular swelling reaction using 446  STEPWISE  PNE'UMOCOCCAL  TRAlqSFORMATION 
antisera prepared against both the smooth and intermediate variants.  In no 
instance was capsular swelling apparent on repeated test, although it could be 
seen readily with the same antisera and smooth organisms grown under con- 
ditions similar for capsular development.  It would appear that although the 
intermediate variant produced SSSII, and even though the polysaccharide is 
disposed on the surface of the cells, the amount is not great enough to give the 
capsular swelling reaction. 
Virulence of the Intermediate  Variant for Mice.--The virulence of the inter- 
mediate D39/Int53 was compared to that of the rough strain R36 by injecting 
mice intraperitoneally with organisms from 18 hour blood broth cultures.  The 
results of this experiment are summarized in Table III.  As shown in Table 
III, 1 cc. of an 18 hour broth culture of D39/Int53 killed all three mice within 
TABLE  III 
Virulence of Intermediate Strain, D39/Int53, and an R Strain, R36, for Mice 
Strain 
D39/Int53 (intermediate  strain) 



















Culture of heart blood 
Intermediate variant only 
R, organisms only 
I 
* Ratio of deaths to survivals. 
~; Survival time of mice that died. 
Surviving mice discarded 7th day. 
approximately 24 hours, whereas 0.5 cc. did not cause death.  Compared with 
the  encapsulated strain  of Type II  pneumococcus, D39/S,  which kills  mice 
regularly in an amount as small as 1  X  10  -8 cc., the intermediate variant is 
comparatively avirulent.  The rough strain, R36, killed 2 of 3 mice when 1 cc. 
of culture was injected and 1 of 3 mice when 0.5  cc. of culture was injected. 
It appears,  therefore, that  the  intermediate variant,  D39/Int53,  is no more 
virulent for mice than the R strain, R36, despite the fact that it produces SSSII 
and that the polysaccharide appears to be a surface component.  The reason 
may be that the intermediate variant does not produce the capsular polysac- 
charide in amounts sufficient to protect itself against phagocytosis. 
Intratype Conversion of R Pneumococci to an Intermediate Variant.--The fore- 
going data demonstrate the existence of an intermediate variant of Type H 
pneumococcus which  forms colonies similar  in  character  to  those of typical 
rough  organisms,  but  nonetheless  synthesizes  the  Type  II  polysaccharide, 
which appears to be disposed on the surface of the cells although in amount 
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intermediate  variant  remained stable  through repeated  subcultures  in  nutrient 
broth,  it  seemed  of  interest  to  determine  whether from  the  cells  a "transfo~ing 
principle"  could  be obtained  which would be capable  of converting  typical  R 
pneumococci  into  variants  of  the  intermediate  type. 
The technique  for  preparing  transforming  extracts  has been  described  under 
Methods.  The R  strain  used for the transformation  reactions,  R36NC, is a 
variant  of  strain  R36 previously  used in transformation  reactions  (7). Strain 
R36NC does not grow diffusely  when cultivated  in anti-R  serum broth but 
remains dumped in the bottom of the tubes. The intermediate  variant,  as 
noted above, grows diffusely  in serum broth.  The property of  diffuse  growth 
TABLE  IV 
Transforraatlon  f R36NC by an Er~ract of g~ I~rnu~ia~ Varlan~ D39/I~53 
Amount of trmnsforming 







Turbidity of culture supernatants 











Identification of org*nlam. 
in supernataat 
Intermediate variant 
~  cc 
Not studied 
R36NC 
* Trace to ++++  designates degree of turbidity  of supernatant,  indicating whether 
transformation has  occurred. 
~: Subculture in 10 per cent serum broth without added transforming extract from D39/ 
Int53. 
in  anti-R  serum broth  was  used  as  an  indication  of whether  conversion of 
R36NC to the intermediate type had occurred in the presence of an extract of 
intermediate cells, since colonies on blood agar of R36NC and the intermediate 
variant derived from it appear identical whether viewed with the naked eye or 
under a colony microscope.  In order to prove that conversion to the intermedi- 
ate  type  had  occurred,  reliance  had  to  be  placed  on  serological  methods. 
Although the means of identifying the converted cells are considerably more 
difficult than in the case of the transformation of R  cells to smooth, encapsu- 
lated  S  forms, it was possible to demonstrate that under  the conditions  de- 
scribed, R36NC can be converted at will into ceils of the intermediate variety. 
Table IV shows the results of a typical experiment. 
No evidence was obtained at any time that strain R36NC was contaminated 
with intermediate mutants corresponding to D39/Int53  as in the case of the 
other R  strain, D39/R19, from which D39/Int53 was selected.  As illustrated 
in  Table  IV,  however,  R36NC  could  be  readily  transformed  into  a  strain 
having  the properties of the  intermediate  variant D39/Int53,  originally ob- 448  STEPWISE  PNEUMOCOCCAL  TRANSFORMATION 
tained by  selection.  Table V  shows a  comparison  of the properties  of the 
original  intermediate  mutant D39/Int53  and  the  transformed intermediate 
mutant R36NC/Int with those of the classical R and S forms of pneumococcus 
Type II. 
In addition to the properties  shown in Table V, antisera prepared in rabbits 
against the respective intermediate variants protected mice to an equal degree 
TABLE V 
Properties  of  Original  Intermediate  D39/In~53,  Tro~formed  l~rmedia~e  R36N/In~,  and 
Classical  S  and  R  Forms of Pneumococcus Type II 
of  ~ro~rti~U ~nsmo~l 
Colony morphology on blood aSaz 
Growth in antt-R serum broth .... 
Reactions in Type II antipneumo- 
coccal serum (anti-D39S) 
Agglutination titer ............. 
Quellung reaction  .............. 
Reactions in antiserum to inter- 
mediate variant D39/int53 
Agglutination titer ............. 
Quellung reaction  .............. 
Reactions in antiserum to intez. 
mediate variant R36NC/Iut 
Agglutination titer ............. 
Qnsllung reaction  .............. 
Character of organisms aggluti- 
nated in Type II antipneumo- 















to break up 
Strains of pneumococcus 
Intermediate 












to break up 
Smooth l~neumo- 


























against  infection by  the fully virulent encapsulated Type II  strain D39S. 
0.001 cc. of either antiserum gave protection against approximately 1000 lethal 
doses of D39S injected intraperitoneaUy. 
Although the properties  described for the two intermediate variants indicate 
strong similarities,  it should not be inferred that they are identical in all re- 
spects.  For example,  colonies of the transformed intermediate R36NC/Int 
resemble closely those of the R strain from which it was derived by transforma- 
tion,  and are  different from the colonies of D39/Int53  in  certain respects. 
These colonial differences indicate the presence  of systems other than that 
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Conversion  of  Intermediate  D39/Int53  into  Fully  Encapsulated  Type  H 
Pneumococci.--Attempts  to  convert  the  intermediate  D39/Int53  to  fully 
encapsulated Type  II  pneumococci  in  vitro were  unsuccessful  using  either 
transforming extracts prepared from Type II S or heat-killed cells.  It should 
be recalled  that the intermediate variant is not agglutinated when grown in 
anti-R serum broth, and since growth in agglomerated  fashion appears to be 
one of the prerequisites  for transformation in vitro (11), it is possible that this 
accounts for the failure.  Other methods for producing agglomeration  of the 
growing  organisms,  such  as  cultivation in  semisolid  agar,  were  not  tried. 
Though unsuccessful in vitro, conversion of the intermediate D39/Int53 to 
Type II S was readily accomplished in vivo by the original Griffith technique 
(9) of injecting mice subcutaneously with a mixture containing small numbers 
TABLE  VI 
Con~ers4on of the  Intermediate Variant  D39/Int53  to  Fully  Encapsulated 
Pneumococcus Type II in Vivo 
Heat-killed pneumococci* 
Type II S (D39S) 
Cg  Cc  c~ 













* 0.4 cc. of a  thick suspension of Type II pneumococcus heated at 65°C. for 30 minutes. 
0.1 cc. of an 18 hour blood broth culture. 
§ Average survival time of mice that died was 79 hours; surviving mice were discarded 
on the 8th day. 
of living organisms of the strain to be converted together with large amounts 
of a heat-killed  suspension of smooth organisms.  Table VI shows the results 
of such an experiment.  Five of the 7 mice injected with D39/Int53 together 
with a heat-killed  vaccine of Type II S died.  From the heart blood of all of 
these animals fully encapsulated Type II pneumococci were recovered, forming 
smooth colonies on agar and virulent for mice.  Proof of the sterility of the 
heat-killed suspension of Type II S was obtained not only by injecting mice 
with 0.4 cc. amounts but also by inoculation into blood broth and on blood 
agar plates. 
Failure  to  Transform  Type  II  Intermediate  D39/Int53  to  Pneumococcus 
Type III.--As noted above,  the intermediate D39/Int53 could be converted 
to Type II S in vivo, though not in vitro by the techniques employed.  It was of 
interest to determine whether it could be transformed to a fully encapsulated 
heterologous  type of pneumococcus.  Repeated attempts both in  vitro and 
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using extracts of Type HI strain A/66 in vitro, and heat-killed suspensions of 
Type HI both in vitro and in vivo.  In addition to anti-R serum in the in vitro 
experiments, in certain instances rabbit antiserum to intermediate D39/Int53, 
previously heated  at  65°C.  to  inactivate  desoxyribonuclease, was  added  in 
order to cause the intermediate strain to 'grow in clumps, but without success. 
Conversion of Rough Strain R36NC to Pneumoeoccus Type H  and Transforma- 
tion to Pneumococcus Type III in a Single Step.--R36NC is convertible to an 
intermediate  form  R36NC/Int,  and  the  intermediate  can  be  converted to 
fully  encapsulated  homologous  pneumococcus  Type  II,  as  shown  above. 
In addition,  R36NC  can be converted to pneumococcus Type II in a  single 
step by cultivation in vitro in the presence of an extract of Type II S.  How- 
ever, it is possible that one or more intermediate phases may appear during the 
course of the progression from R  to S and may be necessary for R-  S con- 
version  to  occur.  Intermediates  appearing  in  the  course  of  "single  step" 
R  S conversion have not been looked for. 
The rough strain R36NC  can also be transformed to pneumococcus Type 
III in vitro, using transforming extracts prepared from strain A/66. 
DISCUSSION 
The experiments described indicate that in the transformation of an R strain 
of pneumococcus to the fully encapsulated S form more than a single character 
may be involved.  Mutants intermediate in respect to SSS production occur 
and conversion can be carried out in two stages, first from R  to intermediate 
and then to the fully encapsulated S form.  On the other hand, transformation 
from R  to S may take place in a single step, apparently without the necessity 
of going through an intermediate phase, although with the usual methods of 
carrying out transformation reactions, intermediate variants would not ordi- 
narily be detected despite  the possibility that  they may occur under  these 
circumstances.  In this regard it should be recalled that detection of transfor- 
marion in vitro has been based primarily on the gross differences in the appear- 
ance of R  and S colonies of pneumococcus, so that even though intermediates 
forming rough colonies were to appear, as in the present studies, they would be 
missed unless special care were used for their detection. 
The  SSSII  synthesized  by  the  intermediate  variant  is  immunologically 
indistinguishable from that formed by encapsulated Type II pneumococci as 
shown  by absorption studies.  The difference in  the  strains  would  seem  to 
reside in  the amount of SSSII produced.  It is possible  that  the S  gene of 
the intermediate differs from that of encapsulated Type II organisms in the 
same respect that alleles for a particular character may differ from each other 
in higher organisms.  On the other hand there may be variation in a separate 
gene system which exercises control over the amount of SSSII formed by the 
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possibility is that the difference between the intermediate and encapsulated 
cells rests in the permeability of the cell wall to SSSII.  An analogy to the 
latter hypothesis is perhaps  to be found in the  case  of secretors  and non- 
secretors of the blood group-specific substances in man, the capacity to secrete 
the group-specific substances being transmitted as a Mendelian dominant (12). 
It is of considerable interest that although the intermediate variant synthe- 
sizes SSSII which is disposed on the surface of the cells, it is not more virulent 
than R  organisms which lack SSSII.  It seems likely that the difference in 
virulence  between  the  intermediate  and  fully  encapsulated  pneumococcns 
Type II is related to the quantity of SSSII synthesized by the respective forms, 
the intermediate producing an amount insufficient  to protect itself  against 
phagocytosis.  If this is the explanation of the difference in mouse virulence of 
these variants, it may be possible in certain instances to account for differences 
in virulence of various strains of smooth pneumococci of the same serological 
type on the basis of the quantity of SSS synthesized.  From this point of view, 
enhancement of a potentially virulent strain on repeated mouse passage, for 
example, would involve selection of variants producing  the most SSS.  There 
seems to be little question that virulence is not related solely to the quantity of 
SSS produced by the various types and strains of pneumococci.  The results of 
the present study indicate,  however,  that this may be one of the important 
factors involved. 
Virtually complete loss of virulence for mice has not affected to a noticeable 
extent the capacity of heat-killed  suspensions of the intermediate variant to 
stimulate the production in rabbits of type-specific antibodies reacting in vitro 
with SSSII and protecting mice against infection with the fully  virulent smooth 
organisms.  Quantitative estimations of the amount of antibody produced in 
rabbits have not been made, but the results  of precipitin,  agglutination, and 
mouse protection tests indicate that the quantity is comparable  to that ordi- 
narily found in the serum of rabbits immunized  with similar amounts of fully 
encapsulated  Type II  pneumococci.  It  may be  suggested  that  studies  of 
attenuated strains of bacteria which have ~been used as immunizing agents for 
specific prophylaxis  might reveal  differences in specific cellular  components 
comparable  to the reduction in SSSII production of the intermediate variant 
described.  In the case of the intermediate variant the amount of SSSII is 
insufficient to permit the strain to exhibit significant virulence, but enough is 
present to act as a potent antigen in rabbits.  It should  also be possible by 
techniques  analogous  to those used in pneumococcal  type transformation to 
"synthesize" bacteria or even viruses  having an appropriate combination of 
avirulence and specific antigenicity. 
Failure of the intermediate variant to be transformed to a heterologous type, 
pneumococcus Type III, may have been due to ignorance of the appropriate 
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if transformation to Type III were to occur, the new strain would be forced to 
synthesize two capsular  polysaccharides at the same time.  It seems unlikely 
that the Type III-synthesizing  pattern could be imposed unless that responsible 
for SSSII production were suppressed or lost through mutation. 
In relation to the attempted transformation to pneumococcus Type III, it is 
of interest that although this transformation did not occur,  neither was the 
Type II intermediate converted  into a  fully encapsulated strain of pneumo- 
coccus Type II by the Type III transforming principle.  It would  appear, 
therefore, that the component responsible for increased SSSII production in the 
fully encapsulated  SII forms, as compared  with the intermediates, is specific 
for SSSII, and not present in Type III cells. 
SUMMARY 
1.  A variant intermediate between  the classical R  and S  forms has been 
isolated by selective procedures from a rough strain of pneumococcus originally 
derived from Type II S. 
2.  The intermediate variant D39/Int53 is avirulent for mice, forms rough 
colonies, and does not possess a  demonstrable capsule.  However,  it synthe- 
sizes SSSII which is immunotogically indistinguishable  from that produced by 
fully encapsulated  pneumococcus Type II, though in much smaller amount. 
The polysaccharide is present as a surface component and as it exists in the cell 
is highly antigenic for rabbits. 
3.  An extract of the intermediate variant causes the transformation in vitro 
of an R strain into a variant resembling the intermediate in SSSII production 
but without any apparent alteration in the colonial characteristics  of the R 
variant. 
4.  The intermediate variant is convertible  in vivo into a fully encapsulated 
strain of pneumococcus  Type II.  Transformation of the intermediate to a 
heterologous type of pneumococcus (Type III) was unsuccessful. 
5.  A method is described  for the preparation of transforming extracts of 
pneumococci  utilizing  the massive  growth of the organisms  obtained in the 
presence of a large concentration of glucose. 
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